Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.
New Diagnostic Criteria for Axial Spondylarthritis
New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.
Opening a New Therapeutic Window for Rheumatoid Arthritis
New targets in rheumatoid arthritis: SYK, JAK, BTK
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
Drug Updates
Information on new approvals and medication safety
Within Our Reach–Funded Research May Hold Key to Unlocking the CNS and Suppressing RA
Studies recently published in Arthritis & Rheumatism show that a key chemical produced by the central nervous system (CNS) decreases inflammation and suppresses production of proteins known to play a role in rheumatoid arthritis (RA). This opens the way for developing a novel class of drugs that mimic this effect of the CNS on RA.
- « Previous Page
- 1
- …
- 3
- 4
- 5